Behind the numbers: AstraZeneca aims for sales of $80 billion by 2030
Published on 22/05/2024 at 14:37, updated on 22/05/2024 at 14:38
Share

The Anglo-Swedish pharmaceutical company is aiming for sales growth of 75% over 7 years. How does it intend to achieve this? The not-to-be-missed story behind important numbers, in just one minute every week!
Share